Asia Pacific Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Application (Drug Discovery, and Drug Development), By Function, By End User, By Country and Growth Forecast, 2024 - 2031

The Asia Pacific Drug Discovery Informatics Market would witness market growth of 10.9% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Drug Discovery Informatics Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $443.5 million by 2031. The Japan market is registering a CAGR of 10.2% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 11.6% during (2024 - 2031).

Rising demand for combination therapies is also leading to an increased demand for drug discovery platforms. Combination therapies often requires the integration and analysis of diverse datasets, including genomic data, clinical data, and drug response data, to identify synergistic drug combinations and optimize treatment regimens. Drug repurposing drives the drug discovery informatics market by leveraging existing knowledge, data, and resources to identify new therapeutic opportunities for existing drugs or compounds.

Additionally, during health crises such as pandemics, there is an urgent need to develop effective therapeutics and vaccines to combat the spread of infectious diseases. Communicable diseases such as malaria, tuberculosis, and HIV/AIDs are increasingly widespread. However, with a rising demand in the drug discovery informatics market, certain factors hinder its growth. High licensing fees and royalties may deter organizations from adopting informatics platforms or restrict their ability to scale up informatics initiatives.

Pharmaceutical companies in Asia, particularly in countries like China, India, and South Korea, are increasing their investment in research and development. This includes investment in informatics platforms and technologies to streamline drug discovery processes, enhance efficiency, and accelerate the development of new drugs. As per China.org.cn, China's pharmaceutical firms saw their combined business revenue climb 18.7 percent year on year in 2021, the highest growth rate in five years. Companies in this sector together raked in 3.37 trillion yuan (about 502 billion U.S. dollars) in revenue in 2020. In 2021, they generated a total of 708.75 billion yuan in profits. Thus, as the expansion of the pharmaceutical sector is expected to continue, Asia will continue to be the key player in the drug discovery informatics market.

Free Valuable Insights: The Global Drug Discovery Informatics Market is Predict to reach USD 6.5 Billion by 2031, at a CAGR of 10.3%

Based on Application, the market is segmented into Drug Discovery, and Drug Development. Based on Function, the market is segmented into Sequencing & Target Data Analysis, Molecular Modelling, Library & Database Preparation, Docking, and Others. Based on End User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• Oracle Corporation
• Accenture PLC
• Thermo Fisher Scientific, Inc.
• Boehringer Ingelheim International GmbH
• Infosys Limited
• Charles River Laboratories International, Inc.
• Agilent Technologies, Inc.
• Illumina, Inc.
• Certara, Inc.
• Jubilant Pharmova Limited

Asia Pacific Drug Discovery Informatics Market Report Segmentation

By Application

• Drug Discovery
• Drug Development

By Function

• Sequencing & Target Data Analysis
• Molecular Modelling
• Library & Database Preparation
• Docking
• Others

By End User

• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Drug Discovery Informatics Market, by Application
1.4.2 Asia Pacific Drug Discovery Informatics Market, by Function
1.4.3 Asia Pacific Drug Discovery Informatics Market, by End User
1.4.4 Asia Pacific Drug Discovery Informatics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.3.2 Key Strategic Move: (Mergers & Acquisition: 2020, Sep – 2023, Dec) Leading Players
4.4 Porter’s Five Forces Analysis

Chapter 5. Asia Pacific Drug Discovery Informatics Market by Application
5.1 Asia Pacific Drug Discovery Market by Country
5.2 Asia Pacific Drug Development Market by Country

Chapter 6. Asia Pacific Drug Discovery Informatics Market by Function
6.1 Asia Pacific Sequencing & Target Data Analysis Market by Country
6.2 Asia Pacific Molecular Modelling Market by Country
6.3 Asia Pacific Library & Database Preparation Market by Country
6.4 Asia Pacific Docking Market by Country
6.5 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific Drug Discovery Informatics Market by End User
7.1 Asia Pacific Pharmaceutical Companies Market by Country
7.2 Asia Pacific Biotechnology Companies Market by Country
7.3 Asia Pacific Contract Research Organizations Market by Country
7.4 Asia Pacific Others Market by Country

Chapter 8. Asia Pacific Drug Discovery Informatics Market by Country
8.1 China Drug Discovery Informatics Market
8.1.1 China Drug Discovery Informatics Market by Application
8.1.2 China Drug Discovery Informatics Market by Function
8.1.3 China Drug Discovery Informatics Market by End User
8.2 Japan Drug Discovery Informatics Market
8.2.1 Japan Drug Discovery Informatics Market by Application
8.2.2 Japan Drug Discovery Informatics Market by Function
8.2.3 Japan Drug Discovery Informatics Market by End User
8.3 India Drug Discovery Informatics Market
8.3.1 India Drug Discovery Informatics Market by Application
8.3.2 India Drug Discovery Informatics Market by Function
8.3.3 India Drug Discovery Informatics Market by End User
8.4 South Korea Drug Discovery Informatics Market
8.4.1 South Korea Drug Discovery Informatics Market by Application
8.4.2 South Korea Drug Discovery Informatics Market by Function
8.4.3 South Korea Drug Discovery Informatics Market by End User
8.5 Singapore Drug Discovery Informatics Market
8.5.1 Singapore Drug Discovery Informatics Market by Application
8.5.2 Singapore Drug Discovery Informatics Market by Function
8.5.3 Singapore Drug Discovery Informatics Market by End User
8.6 Malaysia Drug Discovery Informatics Market
8.6.1 Malaysia Drug Discovery Informatics Market by Application
8.6.2 Malaysia Drug Discovery Informatics Market by Function
8.6.3 Malaysia Drug Discovery Informatics Market by End User
8.7 Rest of Asia Pacific Drug Discovery Informatics Market
8.7.1 Rest of Asia Pacific Drug Discovery Informatics Market by Application
8.7.2 Rest of Asia Pacific Drug Discovery Informatics Market by Function
8.7.3 Rest of Asia Pacific Drug Discovery Informatics Market by End User

Chapter 9. Company Profiles
9.1 Oracle Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Accenture PLC
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.2.6 SWOT Analysis
9.3 Thermo Fisher Scientific, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 Boehringer Ingelheim International GmbH
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.6 SWOT Analysis
9.5 Infosys Limited
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.6 SWOT Analysis
9.6 Charles River Laboratories International, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Recent strategies and developments:
9.6.4.1 Partnerships, Collaborations, and Agreements:
9.6.4.2 Acquisition and Mergers:
9.6.5 SWOT Analysis
9.7 Agilent Technologies, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Acquisition and Mergers:
9.7.6 SWOT Analysis
9.8 Illumina, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segment and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Acquisition and Mergers:
9.8.6 SWOT Analysis
9.9 Certara, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.9.5.3 Acquisition and Mergers:
9.9.6 SWOT Analysis
9.10. Jubilant Pharmova Limited
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 SWOT Analysis

TABLE 1 Asia Pacific Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 2 Asia Pacific Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Drug Discovery Informatics Market
TABLE 4 Product Launches And Product Expansions– Drug Discovery Informatics Market
TABLE 5 Acquisition and Mergers– Drug Discovery Informatics Market
TABLE 6 Asia Pacific Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 7 Asia Pacific Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 8 Asia Pacific Drug Discovery Market by Country, 2020 - 2023, USD Million
TABLE 9 Asia Pacific Drug Discovery Market by Country, 2024 - 2031, USD Million
TABLE 10 Asia Pacific Drug Development Market by Country, 2020 - 2023, USD Million
TABLE 11 Asia Pacific Drug Development Market by Country, 2024 - 2031, USD Million
TABLE 12 Asia Pacific Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 13 Asia Pacific Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 14 Asia Pacific Sequencing & Target Data Analysis Market by Country, 2020 - 2023, USD Million
TABLE 15 Asia Pacific Sequencing & Target Data Analysis Market by Country, 2024 - 2031, USD Million
TABLE 16 Asia Pacific Molecular Modelling Market by Country, 2020 - 2023, USD Million
TABLE 17 Asia Pacific Molecular Modelling Market by Country, 2024 - 2031, USD Million
TABLE 18 Asia Pacific Library & Database Preparation Market by Country, 2020 - 2023, USD Million
TABLE 19 Asia Pacific Library & Database Preparation Market by Country, 2024 - 2031, USD Million
TABLE 20 Asia Pacific Docking Market by Country, 2020 - 2023, USD Million
TABLE 21 Asia Pacific Docking Market by Country, 2024 - 2031, USD Million
TABLE 22 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 23 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 24 Asia Pacific Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 25 Asia Pacific Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 26 Asia Pacific Pharmaceutical Companies Market by Country, 2020 - 2023, USD Million
TABLE 27 Asia Pacific Pharmaceutical Companies Market by Country, 2024 - 2031, USD Million
TABLE 28 Asia Pacific Biotechnology Companies Market by Country, 2020 - 2023, USD Million
TABLE 29 Asia Pacific Biotechnology Companies Market by Country, 2024 - 2031, USD Million
TABLE 30 Asia Pacific Contract Research Organizations Market by Country, 2020 - 2023, USD Million
TABLE 31 Asia Pacific Contract Research Organizations Market by Country, 2024 - 2031, USD Million
TABLE 32 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 33 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 34 Asia Pacific Drug Discovery Informatics Market by Country, 2020 - 2023, USD Million
TABLE 35 Asia Pacific Drug Discovery Informatics Market by Country, 2024 - 2031, USD Million
TABLE 36 China Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 37 China Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 38 China Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 39 China Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 40 China Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 41 China Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 42 China Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 43 China Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 44 Japan Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 45 Japan Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 46 Japan Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 47 Japan Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 48 Japan Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 49 Japan Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 50 Japan Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 51 Japan Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 52 India Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 53 India Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 54 India Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 55 India Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 56 India Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 57 India Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 58 India Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 59 India Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 60 South Korea Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 61 South Korea Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 62 South Korea Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 63 South Korea Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 64 South Korea Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 65 South Korea Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 66 South Korea Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 67 South Korea Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 68 Singapore Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 69 Singapore Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 70 Singapore Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 71 Singapore Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 72 Singapore Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 73 Singapore Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 74 Singapore Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 75 Singapore Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 76 Malaysia Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 77 Malaysia Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 78 Malaysia Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 79 Malaysia Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 80 Malaysia Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 81 Malaysia Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 82 Malaysia Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 83 Malaysia Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 84 Rest of Asia Pacific Drug Discovery Informatics Market, 2020 - 2023, USD Million
TABLE 85 Rest of Asia Pacific Drug Discovery Informatics Market, 2024 - 2031, USD Million
TABLE 86 Rest of Asia Pacific Drug Discovery Informatics Market by Application, 2020 - 2023, USD Million
TABLE 87 Rest of Asia Pacific Drug Discovery Informatics Market by Application, 2024 - 2031, USD Million
TABLE 88 Rest of Asia Pacific Drug Discovery Informatics Market by Function, 2020 - 2023, USD Million
TABLE 89 Rest of Asia Pacific Drug Discovery Informatics Market by Function, 2024 - 2031, USD Million
TABLE 90 Rest of Asia Pacific Drug Discovery Informatics Market by End User, 2020 - 2023, USD Million
TABLE 91 Rest of Asia Pacific Drug Discovery Informatics Market by End User, 2024 - 2031, USD Million
TABLE 92 Key Information – Oracle Corporation
TABLE 93 Key Information – Accenture PLC
TABLE 94 Key Information – Thermo Fisher Scientific, Inc.
TABLE 95 Key Information – Boehringer Ingelheim International GmbH
TABLE 96 Key Information – Infosys Limited
TABLE 97 key information – Charles River Laboratories International, Inc.
TABLE 98 key Information – Agilent Technologies, Inc.
TABLE 99 key information – Illumina, Inc.
TABLE 100 Key Information – Certara, Inc.
TABLE 101 Key Information – Jubilant Pharmova Limited

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Drug Discovery Informatics Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Drug Discovery Informatics Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2020-2024)
FIG 6 Key Strategic Move: (Mergers & Acquisition: 2020, Sep – 2023, Dec) Leading Players
FIG 7 Porter’s Five Forces Analysis - Drug Discovery Informatics Market
FIG 8 Asia Pacific Drug Discovery Informatics Market share by Application, 2023
FIG 9 Asia Pacific Drug Discovery Informatics Market share by Application, 2031
FIG 10 Asia Pacific Drug Discovery Informatics Market by Application, 2020 - 2031, USD Million
FIG 11 Asia Pacific Drug Discovery Informatics Market share by Function, 2023
FIG 12 Asia Pacific Drug Discovery Informatics Market share by Function, 2031
FIG 13 Asia Pacific Drug Discovery Informatics Market by Function, 2020 - 2031, USD Million
FIG 14 Asia Pacific Drug Discovery Informatics Market share by End User, 2023
FIG 15 Asia Pacific Drug Discovery Informatics Market share by End User, 2031
FIG 16 Asia Pacific Drug Discovery Informatics Market by End User, 2020 - 2031, USD Million
FIG 17 Asia Pacific Drug Discovery Informatics Market share by Country, 2023
FIG 18 Asia Pacific Drug Discovery Informatics Market share by Country, 2031
FIG 19 Asia Pacific Drug Discovery Informatics Market by Country, 2020 - 2031, USD Million
FIG 20 SWOT Analysis: Oracle Corporation
FIG 21 SWOT Analysis: Accenture PLC
FIG 22 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 23 SWOT Analysis: Thermo Fisher Scientific, Inc.
FIG 24 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 25 SWOT Analysis: Infosys Limited
FIG 26 Recent strategies and developments: Charles River Laboratories International, Inc.
FIG 27 Swot Analysis: Charles River Laboratories International, Inc.
FIG 28 Recent strategies and developments: Agilent Technologies, Inc.
FIG 29 Swot Analysis: Agilent Technologies, Inc.
FIG 30 Recent strategies and developments: Illumina, Inc.
FIG 31 Swot Analysis: Illumina, Inc.
FIG 32 Recent strategies and developments: Certara, Inc.
FIG 33 Swot Analysis: Certara, Inc.
FIG 34 Swot Analysis: Jubilant Pharmova Limited